Butacod (Butamirate Citrate) is a cough suppressant that acts directly on the brain's cough center. It is used to relieve dry cough caused by viral infections or for pre- and post-operative cough sedation. Butacod comes in tablet and syrup forms and works within 30 minutes for up to 12 hours. It is rapidly absorbed and extremely protein bound, with a plasma elimination half-life of around 13 hours. Butacod has few side effects and is generally well tolerated, with adverse reactions like rash, nausea and diarrhea occurring in approximately 1% of cases.
Butacod (Butamirate Citrate) is a cough suppressant that acts directly on the brain's cough center. It is used to relieve dry cough caused by viral infections or for pre- and post-operative cough sedation. Butacod comes in tablet and syrup forms and works within 30 minutes for up to 12 hours. It is rapidly absorbed and extremely protein bound, with a plasma elimination half-life of around 13 hours. Butacod has few side effects and is generally well tolerated, with adverse reactions like rash, nausea and diarrhea occurring in approximately 1% of cases.
Butacod (Butamirate Citrate) is a cough suppressant that acts directly on the brain's cough center. It is used to relieve dry cough caused by viral infections or for pre- and post-operative cough sedation. Butacod comes in tablet and syrup forms and works within 30 minutes for up to 12 hours. It is rapidly absorbed and extremely protein bound, with a plasma elimination half-life of around 13 hours. Butacod has few side effects and is generally well tolerated, with adverse reactions like rash, nausea and diarrhea occurring in approximately 1% of cases.
Overview: Butamirate Citrate is a Cough Suppressant that acts directly on the brain’s cough center to suppress cough. It is used to relieve dry (non-productive) cough. Dry cough may be caused by a recent viral infection. Butamirate Citrate is also used for pre & post-operative cough sedation in patients who will undergo surgical procedures and bronchoscopy. Presentation Table : 50 mg Syrup : 7.5 mg/ 5 ml Preparation Butacod SR Tablet: Each sustained release tablet contains Butamirate Citrate 50 mg. Butacod Syrup: Each 5 ml syrup contains Butamirate Citrate 7.5 mg. Pharmacology Butamirate Citrate acts directly on the brain’s cough center to suppress cough. It is rapidly absorbed and begins working 30 minutes after first administration. Its long-lasting action works up to 12 hours. Butamirate Citrate is safe, codeine-free, non-narcotic & non-sedating. Mode of Action: Butamirate Citrate acts directly on the brain's cough center to suppress cough. Pharmacokinetics: Butamirate citrate is rapidly and completely absorbed after oral administration. Maximum concentration is reached within 9 hours with sustain release tablet. Butamirate citrate is extremely protein bound and Plasma elimination half-life is about 13 hours. Indication Butamirate Citrate is used to relieve dry (non-productive) cough. Dry cough may be caused by a recent viral infection. Butamirate Citrate is also used for pre & post-operative cough sedation in patients who will undergo surgical procedures and bronchoscopy. Dose and Administration Butacod SR Tablet: Adolescents over 12 years old: 1-2 tablets daily Adults : 2-3 tablets daily at 8 to 12 hours intervals. Butacod Syrup: Children (3-6 years of age): 5 ml 3 times daily. 6-12 years: 10 ml 3 times daily. Adults : 15 ml 4 times daily. Contraindication When the patient is hypersensitive to the active substance or any of the excipients. Warning & Precautions No special precautions Side Effects Tolerance of Butamirate Citrate is good. Adverse reactions such as rash, nausea, diarrhoea and vertigo have been observed in a few rare cases (a total of approximately 1% of treated cases in clinical trials), resolving after dose reduction or treatment withdrawal. Drug Interaction Interaction with Aspirin, Simvastatin, Warfarin, Omeprazole, Furosemide, Ramipril, Acetaminophen etc. Use in special groups Pregnancy and Lactation No adverse fetal effects have been observed in animal reproduction studies, and there have been no controlled studies in pregnant women. Butamirate Citrate should therefore not be used during the first trimester of pregnancy. During the remainder of pregnancy, Butamirate Citrate can be used if definitely indicated by a physician but with caution. As a general rule, for safety reasons, in the absence of data on elimination of the active substance in breast milk, the benefits of Butamirate Citrate administration during breast feeding should be carefully weighed against the risks. Storage Keep away from light and moisture, store below 30°C. Keep all the medicines out of the reach of children. Commercial Pack Butacod SR Tablet: Each box contains 3 x 10 tablets in Alu-Alu blister pack. Butacod Syrup: Each bottle contains 100 ml syrup.